BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 26608346)

  • 21. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis.
    Mori S; Koga Y; Sugimoto M
    Respir Med; 2012 Nov; 106(11):1591-9. PubMed ID: 22867979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.
    Doyle TJ; Dellaripa PF; Batra K; Frits ML; Iannaccone CK; Hatabu H; Nishino M; Weinblatt ME; Ascherman DP; Washko GR; Hunninghake GM; Choi AMK; Shadick NA; Rosas IO
    Chest; 2014 Jul; 146(1):41-50. PubMed ID: 24305643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
    Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease.
    Ota M; Iwasaki Y; Harada H; Sasaki O; Nagafuchi Y; Nakachi S; Sumitomo S; Shoda H; Tohma S; Fujio K; Yamamoto K
    Mod Rheumatol; 2017 Jan; 27(1):22-28. PubMed ID: 27142966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus.
    Yang CF; Wu MT; Chiang AA; Lai RS; Chen C; Tiao WM; McLoud TC; Wang JS; Pan HB
    AJR Am J Roentgenol; 1997 Apr; 168(4):1045-50. PubMed ID: 9124113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
    Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis.
    Rocha-Muñoz AD; Ponce-Guarneros M; Gamez-Nava JI; Olivas-Flores EM; Mejía M; Juárez-Contreras P; Martínez-García EA; Corona-Sánchez EG; Rodríguez-Hernández TM; Vázquez-del Mercado M; Salazar-Páramo M; Nava-Zavala AH; Cardona-Muñoz EG; Celis A; González-Lopez L
    J Immunol Res; 2015; 2015():151626. PubMed ID: 26090479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
    Jacob J; Bartholmai BJ; Rajagopalan S; Egashira R; Brun AL; Kokosi M; Nair A; Walsh SLF; Karwoski R; Nicholson AG; Hansell DM; Wells AU
    Respir Med; 2017 Sep; 130():43-51. PubMed ID: 29206632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Damage in Rheumatoid Arthritis-A Retrospective Study.
    Dinache G; Popescu CC; Mogoșan C; Enache L; Agache M; Codreanu C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.
    Solomon JJ; Chung JH; Cosgrove GP; Demoruelle MK; Fernandez-Perez ER; Fischer A; Frankel SK; Hobbs SB; Huie TJ; Ketzer J; Mannina A; Olson AL; Russell G; Tsuchiya Y; Yunt ZX; Zelarney PT; Brown KK; Swigris JJ
    Eur Respir J; 2016 Feb; 47(2):588-96. PubMed ID: 26585429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thin-section CT imaging that correlates with pulmonary function tests in obstructive airway disease.
    Arakawa H; Fujimoto K; Fukushima Y; Kaji Y
    Eur J Radiol; 2011 Nov; 80(2):e157-63. PubMed ID: 20619989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)-associated Bronchiectasis: Role of RA-related Autoantibodies.
    McDermott G; Gill R; Gagne S; Byrne S; Huang W; Wang X; Prisco LC; Zaccardelli A; Martin LW; Masto L; Kronzer VL; Shadick N; Dellaripa PF; Doyle TJ; Sparks JA
    J Rheumatol; 2022 Jul; 49(7):672-679. PubMed ID: 35293341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.
    Edwards EA; Metcalfe R; Milne DG; Thompson J; Byrnes CA
    Pediatr Pulmonol; 2003 Aug; 36(2):87-93. PubMed ID: 12833486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The 456th case: polyarthritis, dry cough, dyspnea on exertion].
    Li Y; Ren XY; Sun F; Wang P; Zhao JL; Wu QJ; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):388-392. PubMed ID: 28460514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.